Neurological Manifestations of Thyroid Disease Workup

  • Author: Gabriel Bucurescu, MD, MS; Chief Editor: Nicholas Lorenzo, MD   more...
 
Updated: Oct 17, 2011
 

Laboratory Studies

  • Blood levels of thyroid hormone and serum thyrotropin (ie, TSH) are the most important diagnostic tests. levels of free T4 and free T3 in serum provide a better assessment of the thyroid status than total T4 and T3. The levels of T4 and T3 are decreased in hypothyroidism, and they are increased in hyperthyroidism.
  • Serum TSH levels range from 0.5 to 5.0 microunits per milliliter. TSH is increased in hypothyroidism, and as thyroid function becomes autonomous, it decreases. It is a useful marker for the efficacy of therapy. The TSH-immunometric assay (TSH-IMA) can discriminate directly between normal TSH and reduced levels without requiring the use of the thyrotropin-releasing hormone (TRH) infusion test. If TSH levels remain high in cases of treated hypothyroidism, the possibility of a TSH-secreting pituitary adenoma should be considered.
  • TRH infusion test can be performed by infusing TRH intravenously and measuring TSH in serum to determine the presence of TSH in the pituitary. TSH is reduced in hyperthyroidism in autonomous thyroid production and hypothalamic pituitary disease. This test has been superseded by the TSH-IMA.
  • Thyroid hormone-binding ratio (known previously as T4 and T3 uptake) and transthyretin levels are rarely useful for common clinical purposes.
  • Radioactive iodine (RAI) uptake can differentiate causes of hyperthyroidism: subacute thyroiditis (low uptake) versus Graves disease (high uptake).
  • Antithyroid antibodies, the most important being thyroid microsomal antibody (TMAb), are seen in 95% of patients with Hashimoto thyroiditis but in only 10% of adults with no disease. In Graves disease, 55% of patients have circulating TMAbs. Recently, in a small study, antithyroid antibodies were found to be the most common abnormality in a group of patients with autoimmune manifestations and atypical neurologic features.
  • Antithyroperoxidase antibodies from patients with Hashimoto encephalopathy were found to bind to cerebellar cells expressing glial fibrillary acid protein.[5]
  • Thyroglobulin antibodies (TGAbs) are present in the serum of 60% of patients with Hashimoto disease.
  • Interestingly, increased levels of thyroglobulin antibodies and/or antithyroid peroxidase antibodies have been found in patients with aquaporin-4 (AQP4) antibody–positive CNS autoimmunity and multiple sclerosis, both in pediatric and adult age groups. AQP4 antibody plays an important role in the pathophysiology of neuromyelitis optica (NMO) spectrum disorders, and such patients have a high frequency of autoimmune thyroid disease.[6]
  • Antibodies against thyroid TSH receptor (TRAbs) are seen in the serum of patients with Graves disease.
  • Serum thyroglobulin is most useful in follow-up of metastatic thyroid carcinoma after thyroidectomy.
  • Creatine kinase (CK) levels may be elevated.
  • Cerebrospinal fluid (CSF) protein may be increased.
Next

Imaging Studies

  • Imaging studies such as MRI or CT scan are of limited use in thyroid disease. Pituitary or hypothalamic tumors can be seen, as can metastatic lesions of thyroid carcinoma, which are usually solitary. In cases of severe exophthalmic ophthalmoplegia, extraocular muscle swelling can be observed on both MRI and CT scans (sometimes impinging on the optic nerve). Brains of adults with congenital hypothyroidism may show atrophy, especially of the brain stem and perisylvian regions (with cerebellum sparing). Patients with antibodies against thyroid antigens may show nonspecific MRI changes, probably due to demyelination.
  • Thyroid scan (which involves either radioactive iodine 123 or iodine 131) correlates thyroid function and structure. It can diagnose the functional state of a thyroid nodule or search for thyroid tissue in neck masses.
  • Thyroid ultrasound can assess whether a thyroid mass is solid or cystic. It is used usually to help in diagnosing a single thyroid nodule; cystic lesions may be simple cysts or benign follicular tumors, which could be managed medically, sparing the patient the need for surgery. However, follicular carcinoma also can become cystic, in which case tissue biopsy would be required. Solid masses suggest a possible tumor, in which case the treating physician would be inclined to proceed to surgery.
Previous
Next

Other Tests

  • Electroencephalography in hyperthyroidism
    • EEG may support the suspicion of CNS involvement.
    • Alpha rhythm is accelerated, and rolandic mu rhythm may be augmented.
    • Some have reported paroxysmal bursts and clinical seizures (eg, grand mal).
    • Patients with epilepsy and thyroid dysfunction may respond poorly to anticonvulsants until the underlying endocrine problem is treated.
    • Thyroxine can produce epileptic activity.
    • In thyrotoxic crises with encephalopathy, EEG abnormalities are characterized by marked slowing with superimposed fast activity.
    • Triphasic waves are reported rarely.
  • Electroencephalography in hypothyroidism
    • EEG is characterized by an excess of low-voltage activity with a poor or absent alpha-blocking response.
    • In myxedematous coma, slow, low-voltage activity predominates.
    • Generalized periodic sharp wave discharges, mimicking Jakob-Creutzfeldt encephalopathy, have been reported in one case.
    • EEG abnormalities tend to resolve as thyroid abnormalities are treated.
    • In myxedematous infants, delay in EEG development (especially of sleep spindle) can occur.
    • Generally, EEG shows excessive low-voltage slowing.
  • Electromyography
    • EMG generally provides limited information.
    • Proximal muscles are more likely to show an abnormal pattern than distal muscles.
    • In hyperthyroid patients, abnormalities include reduced duration of mean action potentials and increased mean percentage of polyphasic potentials.
    • Large action potentials may be seen in thyrotoxic myopathy but are not associated histologically with neuropathic change and are not believed to indicate denervation.
    • In hypothyroidism, EMG changes include polyphasic action potentials, hyperirritability, repetitive discharges after reflex motion, and low-voltage, short-duration motor unit potentials. Changes usually resolve as thyroid function normalizes.
  • Nerve conduction studies
    • Nerve conduction velocities (NCV) are decreased in hypothyroid patients with polyneuropathy
      • Patients show diffuse sensory neuropathy due to axonal degeneration and not, as previously thought, to segmental demyelination.
      • Amplitude of sensory compound nerve action potentials (CNAP) is reduced and NCVs are slowed.
      • In carpal tunnel syndrome, typical nerve conduction abnormalities are seen.
    • One case was reported of severe hyperthyroidism with motor-sensory neuropathy, moderately slow NCVs, absent sural CNAP, and low sural sensory NCV.
    • Thyrotoxic neuropathy (also known as Basedow paraplegia) is very rare.
  • Evoked potential studies
    • Generally these are not useful in thyroid disease.
    • Visual evoked potentials show increased latencies in hyperthyroidism with no change after patients become euthyroid.
    • In hypothyroid patients, amplitudes are decreased and latencies are prolonged.
    • Latencies and amplitudes improved inconsistently among some patients as thyroid function normalized.
    • Brainstem evoked responses are marginally useful, with some studies showing abnormalities.
    • Patients who had been hyperthyroid for longer than 6 months showed increased N19-P23 amplitudes in median somatosensory evoked potentials with the latency unaffected.
Previous
Next

Procedures

  • Thyroidectomy
  • Fine-needle biopsy
  • Muscle or peripheral nerve biopsy: This can confirm diagnosis or differentiate diagnoses. Both hyperthyroid and hypothyroid patients may have disturbed levels of carnitine but by separate mechanisms.[7]
Previous
Next

Histologic Findings

  • Hypothyroidism
    • Sural nerve biopsies - Axonal degeneration
    • Electron microscopy
      • Focal microfibrillar disorganization, sometimes with nemaline rods
      • Mitochondrial accumulation
      • Occasional basophilic degeneration: In cardiac and skeletal muscle, basophilic degeneration is due to deposits of polysaccharide material.
      • No definite abnormalities in muscle from individuals with congenital hypothyroidism
    • Muscle histology
      • Type I fiber excess
      • Atrophy of type I and II fibers
      • Altered oxidative enzyme activity, abnormal collection of glycogen, peripheral crescents, and distention of cytoplasmic reticulum
      • Vacuolar myopathy
      • Increased central nuclear counts
      • Central cores with oxidative activity in type I fibers
      • Impaired myelin formation
  • Hyperthyroidism
    • Sural nerve biopsies
      • Excessive axonal branching
      • Degenerative changes of preterminal axons
      • Edematous protein infiltration of endoneurium and perineurium
      • Segmental demyelination in teased fiber preparation
    • Electron microscopy
      • Increased glycogen, acid mucopolysaccharides, and aggregates of glycogen and cytoplasmic laminar bodies in Schwann cells
      • In brain, small neuronal cell bodies with increased cell packing density, decreased neurophil, decreased myelin, and gliosis (especially in the substantia nigra and globus pallidus)
    • Muscle histology
      • Few pathologic changes in hyperthyroidism
      • Mild atrophy, infiltration of fat cells, nonspecific focal myofibrillar degeneration, mitochondrial hypertrophy, and focal dilatation of transverse tubular system
Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Gabriel Bucurescu, MD, MS  Staff Neurologist, Neurology Service, Philadelphia Veterans Affairs Medical Center

Gabriel Bucurescu, MD, MS is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, and American Epilepsy Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Thomas A Kent, MD  Professor and Director of Stroke Research and Education, Department of Neurology, Baylor College of Medicine; Chief of Neurology, Michael E DeBakey Veterans Affairs Medical Center

Thomas A Kent, MD is a member of the following medical societies: American Academy of Neurology, American Neurological Association, New York Academy of Sciences, Royal Society of Medicine, Sigma Xi, and Stroke Council of the American Heart Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Agapito S Lorenzo, MD  Laboratory Director, Associate Professor, Departments of Neurology, Creighton University and University of Nebraska Medical Center

Agapito S Lorenzo, MD is a member of the following medical societies: American Academy of Neurology and American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Chief Editor

Nicholas Lorenzo, MD  Consulting Staff, Neurology Specialists and Consultants

Nicholas Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, and American College of Physician Executives

Disclosure: Nothing to disclose.

References

  1. Guimaraes J, Santos L, Bugalho P. Painful legs and moving toes syndrome associated with Hashimoto's disease. Eur J Neurol. Mar 2007;14(3):343-5. [Medline].

  2. Chia SY, Chua R, Lo YL, Wong MC, Chan LL, Tan EK. Acute ataxia, Graves' disease, and stiff person syndrome. Mov Disord. Oct 15 2007;22(13):1969-71. [Medline].

  3. Ohba S, Nakagawa T, Murakami H. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment. Neurosurg Rev. Jul 2011;34(3):297-304; discussion 304. [Medline].

  4. Scorza FA, Arida RM, Cysneiros RM, Terra VC, de Albuquerque M, Machado HR. Subclinical hyperthyroidism and sudden unexpected death in epilepsy. Med Hypotheses. Apr 2010;74(4):692-4. [Medline].

  5. Blanchin S, Coffin C, Viader F, Ruf J, Carayon P, Potier F, et al. Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J Neuroimmunol. Dec 2007;192(1-2):13-20. [Medline].

  6. Sellner J, Kalluri SR, Cepok S, Hemmer B, Berthele A. Thyroid antibodies in aquaporin-4 antibody positive central nervous system autoimmunity and multiple sclerosis. Clin Endocrinol (Oxf). Aug 2011;75(2):271-2. [Medline].

  7. Sinclair C, Gilchrist JM, Hennessey JV, Kandula M. Muscle carnitine in hypo- and hyperthyroidism. Muscle Nerve. Sep 2005;32(3):357-9. [Medline].

  8. Alevizaki M, Synetou M, Xynos K, Alevizaki CC, Vemmos KN. Hypothyroidism as a protective factor in acute stroke patients. Clin Endocrinol (Oxf). Sep 2006;65(3):369-72. [Medline].

  9. Dai A, Wasay M, Dubey N, Giglio P, Bakshi R. Superior sagittal sinus thrombosis secondary to hyperthyroidism. J Stroke Cerebrovasc Dis. Mar-Apr 2000;9(2):89-90. [Medline].

  10. Ni J, Gao S, Cui LY, Li SW. Intracranial arterial occlusive lesion in patients with Graves' disease. Chin Med Sci J. Sep 2006;21(3):140-4. [Medline].

  11. Peralta AR, Canhão P. Hypothyroidism and cerebral vein thrombosis--a possible association. J Neurol. Jul 2008;255(7):962-6. [Medline].

  12. Adams RD, Victor M, Ropper AH. The endocrine myopathies. In: 6th ed. Principles of Neurology. 1997. New York: McGraw-Hill; 1440-2.

  13. Ahdab R, Thomas D. Palatal tremor, focal seizures, repeated miscarriages and elevated anti-thyroid antibodies. Clin Neurol Neurosurg. Apr 2008;110(4):381-3. [Medline].

  14. Avramides A, Papamargaritis K, Mavromatis I, et al. Visual evoked potentials in hypothyroid and hyperthyroid patients before and after achievement of euthyroidism. J Endocrinol Invest. 1992;15:749-753. [Medline].

  15. Boyages SC, Halpern J-P. Endemic cretinism: toward a unifying hypothesis. Thyroid. 1993;3(1):59-69. [Medline].

  16. Calza L, Aloe L, Giardino L. Thyroid hormone-induced plasticity in the adult rat brain. Brain Res Bull. 1997;44(4):549-57. [Medline].

  17. Chang T, Riffsy MT, Gunaratne PS. Hashimoto encephalopathy: clinical and MRI improvement following high-dose corticosteroid therapy. Neurologist. Nov 2010;16(6):394-6. [Medline].

  18. Comi AM, Bellamkonda S, Ferenc LM, Cohen BA, Germain-Lee EL. Central hypothyroidism and Sturge-Weber syndrome. Pediatr Neurol. Jul 2008;39(1):58-62. [Medline].

  19. DeLong GR. The neuromuscular system and brain in hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 7th ed. Philadelphia: Lippincott-Raven; 1996:826-35.

  20. DeLong GR. The neuromuscular system and brain in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 7th ed. Philadelphia: Lippincott-Raven; 1996:645-52.

  21. Donati L, Antonelli A, Bertoni F, et al. Clinical picture of endemic cretinism in central Apennines (Montefeltro). Thyroid. 1992;2(4):283-290. [Medline].

  22. Duhig TJ, McKeag D. Thyroid disorders in athletes. Curr Sports Med Rep. Jan-Feb 2009;8(1):16-9. [Medline].

  23. Ferracci F, Carnevale A. The neurological disorder associated with thyroid autoimmunity. J Neurol. Aug 2006;253(8):975-84. [Medline].

  24. Halpern J-P, Boyages SC, Maberly GF, et al. The neurology of endemic cretinism. Brain. 1991;114:825-841. [Medline].

  25. Hsieh MJ, Lyu RK, Chang WN, Chang KH, Chen CM, Chang HS, et al. Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. Eur J Neurol. Jun 2008;15(6):559-64. [Medline].

  26. Jagannathan NR, Tandon N, Raghunathan P, Kochupillai N. Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. Brain Res Dev Brain Res. Aug 8 1998;109(2):179-86. [Medline].

  27. Kurne A, Aydin OF, Karabudak R. White matter alteration in a patient with Graves' disease. J Child Neurol. Sep 2007;22(9):1128-31. [Medline].

  28. Lai CL, Liu CK, Tai CT, et al. A study of central and peripheral nerve conduction in patients with primary hypothyroidism: the effects of thyroxine replacement. Kaohsiung J Med Sci. May 1998;14(5):294-302. [Medline].

  29. Larsen PR. The thyroid. In: Wyngaarden JB, Smith LH Jr, Bennett JC, et al, eds. Cecil Textbook of Medicine. 19th ed. Philadelphia: Saunders; 1992:1248-71.

  30. Li L, Zheng FP, Wang G, Li H. Recurrent hashimoto's encephalopathy, showing spontaneous remission: a case report. Intern Med. 2011;50(12):1309-12. [Medline].

  31. Losa M, Mortini P, Minelli R, Giovanelli M. Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism. J Endocrinol Invest. 2006;29:555-559. [Medline].

  32. Madeira MD, Cadete-Leite A, Andrade JP, et al. Effects of hypothyroidism upon the granular layer of the dentate gyrus in male and female adult rats: a morphometric study. J Comp Neurol. Dec 1 1991;314(1):171-86. [Medline].

  33. Marta CB, Adamo AM, Soto EF, Pasquini JM. Sustained neonatal hyperthyroidism in the rat affects myelination in the central nervous system. J Neurosci Res. Jul 15 1998;53(2):251-9. [Medline].

  34. Mavragani CP, Patronas N, Dalakas M, Moutsopoulos HM. Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge. J Rheumatol. Feb 2007;34(2):341-5. [Medline].

  35. Muthipeedika JM, Moosa A, Kumar A, Suchowersky O. Bilateral chorea--ballism associated with hyperthyroidism. Mov Disord. Apr 2005;20(4):512; author reply 512. [Medline].

  36. Ozata M, Ozkardes A, Corakci A, Gundogan MA. Subclinical hypothyroidism does not lead to alterations either in peripheral nerves or in brainstem auditory evoked potentials (BAEPs). Thyroid. 1995;5(3):201-205. [Medline].

  37. Ozata M, Ozkardes A, Dolu H, et al. Evaluation of central motor conduction in hypothyroid and hyperthyroid patients. J Endocrinol Invest. 1996;19:670-677. [Medline].

  38. Ozkan Y, Colak R. Sheehan syndrome: clinical and laboratory evaluation of 20 cases. Neuro Endocrinol Lett. Jun 2005;26(3):257-60. [Medline].

  39. Ozkardes A, Ozata M, Beyhan Z, et al. Acute hypothyroidism leads to reversible alterations in central nervous system as revealed by somatosensory evoked potentials. Electroencephalography and clinical neurophysiology. 1996;100:500-504. [Medline].

  40. Parker RJ, Davidson AC. Hypothyroidism--an unexpected diagnosis following emergency treatment for heatstroke. Int J Clin Pract Suppl. Apr 2005;31-3. [Medline].

  41. Perelman AH, Clemons RD. The fetus in maternal hyperthyroidism. Thyroid. 1992;2(3):225-228. [Medline].

  42. Powner DJ, Boccalandro C, Alp MS, Vollmer DG. Endocrine failure after traumatic brain injury in adults. Neurocrit Care. 2006;5(1):61-70. [Medline].

  43. Quattrini A, Nemni R, Marchettini P, et al. Effect of hypothyroidism on rat peripheral nervous system. Neuroreport. 1993;4:499-502. [Medline].

  44. Sahni V, Gupta N, Anuradha S, Tatke M, Kar P. Thyrotoxic neuropathy- an under diagnosed condition. Med J Malaysia. Mar 2007;62(1):76-7. [Medline].

  45. Santoro D, Colombo I, Ghione I, Peverelli L, Bresolin N, Sciacco M. Steroid-responsive Hashimoto encephalopathy mimicking Creutzfeldt-Jakob disease. Neurol Sci. Aug 2011;32(4):719-22. [Medline].

  46. Somay G, Oflazoglu B, Us O, Surardamar A. Neuromuscular status of thyroid diseases: a prospective clinical and electrodiagnostic study. Electromyogr Clin Neurophysiol. Mar-Apr 2007;47(2):67-78. [Medline].

  47. Tamburini G, Tacconi P, Ferrigno P, et al. Visual evoked potentials in hypothyroidism: a long-term evaluation. Electromyogr Clin Neurophysiol. 1998;38:201-205. [Medline].

  48. Tuncel D, Cetinkaya A, Kaya B, Gokce M. Hoffmann's syndrome: a case report. Med Princ Pract. 2008;17(4):346-8. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.